Three years of intense work and this is the result!!
“Enhancer mapping uncovers phenotypic heterogeneity and evolution in patients with luminal breast cancer” is our new effort published in the prestigious journal Nature Medicine.
We give for the first time a topographic overview of the active regulatory region in ERa+ Breast Cancer, and we highlight the role of YY1 (the new MYC?). Enhancers are critical players of tumour progression, and we track their dynamics along the disease. This and much more in the new paper.
Great job guys and let’s keep working hard!!
Check the press review